Especially due to the predominant expression of A20 on stromal tumor infiltrating CD3+ T cells, further research, especially in regards to establishing innovative treatment concepts such as immune checkpoint therapies, is highly needed. The gene discussed is TNFAIP3; the disease is neoplasm.